Amgen (AMGN) Tops Q1 EPS by 35c, Offers Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $437.23 -1.55%
EPS Growth %: +2.7%
Financial Fact:
Other charges: 23M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +2.7%
Financial Fact:
Other charges: 23M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $5.15, $0.35 better than the analyst estimate of $4.80. Revenue for the quarter came in at $8.62 billion versus the consensus estimate of $8.59 billion.
GUIDANCE:
Amgen sees FY2026 EPS of $21.70-$23.10, versus the consensus of $22.30. Amgen sees FY2026 revenue of $37.1-38.5 billion, versus the consensus of $37.79 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
